Background illustration for clinical trials search

Paid Clinical Trials Little Rock

Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

for
Diabetic Kidney Disease (DKD)
Location: Little Rock AR, Monroe LA, McKinney TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07271186

Phase2, Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Little Rock AR, Memphis TN, Dallas TX, St Louis MO,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Little Rock AR, Springfield MO, Ridgeland MS, Tulsa OK,
Sponsor: Kallyope Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Little Rock AR, Shreveport LA, Jackson TN, Plano TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase3, Recruiting

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: Little Rock AR, Tyler TX, Baytown TX, Houston TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT06598943

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

for
Immunoglobulin A Nephropathy (IgAN)
Location: Little Rock AR, Brookhaven MS, Dallas TX, Houston TX,
Sponsor: Biogen

Sex: All

Age: 18+

Code: NCT06935357

Phase3, Recruiting

Abbott Vascular Medical Device Registry

for
Acute Myocardial Infarction, Restenoses, Coronary,
Location: Little Rock AR, Birmingham AL, Lincoln NE, Chicago IL,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT04573660

Recruiting

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

for
Hypogonadism
Location: Little Rock AR, Flower Mound TX, Birmingham AL,
Sponsor: Acerus Pharmaceuticals Corporation

Sex: Male

Age: 18 - 70+

Code: NCT04976595

Recruiting

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

for
Attention-Deficit/Hyperactivity Disorder
Location: Little Rock AR, Memphis TN, Flowood MS, Dallas TX,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 4 - 5

Code: NCT04781140

Recruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

for
Overactive Bladder, Urge Incontinence, Incontinence, Urinary,
Location: Little Rock AR, St Louis MO, Arlington TX,
Sponsor: Valencia Technologies Corporation

Sex: All

Age: 18+

Code: NCT05685433

Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Little Rock AR, Memphis TN, St Louis MO, Arlington TX,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Little Rock AR, Fayetteville AR, Springdale AR,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Little Rock AR, Southhaven MS, Germantown TN, Dallas TX,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase3, Recruiting

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

for
Benign Prostatic Hyperplasia
Location: Little Rock AR, Shreveport LA, Houston TX, Austin TX,
Sponsor: Urotronic Inc.

Sex: Male

Age: 50+

Code: NCT06312722

Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Little Rock AR, Dallas TX, Birmingham AL, Nashville TN,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: Little Rock AR, Tulsa OK, Dallas TX, Nashville TN,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase3, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Little Rock AR, Southaven MS, Germantown TN,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Little Rock AR, Jackson MS, St Louis MO, Dallas TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

for
Non-Muscle Invasive Bladder Neoplasms
Location: Little Rock AR, St Louis MO, Dallas TX, Arlington TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07309445

Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Little Rock AR, St Louis MO, Arlington TX, Houston TX,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT07480356

Phase3, Recruiting